Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Depreciation & Amortization (CF) of $706000.0 in Q1 2026, down 10.63% quarter-over-quarter from $790000.0 in Q4 2025, and down 16.65% year-over-year from $847000.0 in Q1 2025.
Rapid Micro Biosystems' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $706000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 16.65% year-over-year to $706000.0; the TTM figure through Mar 2026 stood at $3.1 million (down 8.58% YoY), while the FY2025 annual figure was $3.3 million, down 3.27% from the prior year.
- Depreciation & Amortization (CF) came in at $706000.0 for Q1 2026 at Rapid Micro Biosystems, down from $790000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $869000.0 in Q4 2024 to a low of $560000.0 in Q1 2022.
- A 5-year average of $780117.6 and a median of $794000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) jumped 127.67% in 2022 and retreated 16.65% in 2026, its largest moves.
- Rapid Micro Biosystems' Depreciation & Amortization (CF) stood at $860000.0 in 2022, then fell by 7.67% to $794000.0 in 2023, then grew by 9.45% to $869000.0 in 2024, then slipped by 9.09% to $790000.0 in 2025, then dropped by 10.63% to $706000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $706000.0, $790000.0, and $804000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | 706,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 706,000.00 |
| Mar 31, 2026 | 706,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Dec 31, 2023 | 794,000.00 |
| Dec 31, 2023 | 794,000.00 |
| Sep 30, 2023 | 781,000.00 |
| Sep 30, 2023 | 781,000.00 |
| Jun 30, 2023 | 771,000.00 |
| Jun 30, 2023 | 771,000.00 |
| Mar 31, 2023 | 759,000.00 |
| Mar 31, 2023 | 759,000.00 |
| Dec 31, 2022 | 860,000.00 |
| Dec 31, 2022 | 860,000.00 |
| Sep 30, 2022 | 734,000.00 |
| Sep 30, 2022 | 734,000.00 |
| Jun 30, 2022 | 683,000.00 |
| Jun 30, 2022 | 683,000.00 |
| Mar 31, 2022 | 560,000.00 |
| Mar 31, 2022 | 560,000.00 |
| Dec 31, 2021 | 450,000.00 |
| Dec 31, 2021 | 450,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Dec 31, 2020 | 310,000.00 |
| Dec 31, 2020 | 310,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 400,000.00 |